Frontier Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,003
Closed -$431K 268
2022
Q3
$431K Sell
8,003
-68,767
-90% -$3.53M 0.01% 264
2022
Q2
$3.1M Sell
76,770
-305,554
-80% -$15.1M 0.04% 260
2022
Q1
$25.3M Sell
382,324
-64,510
-14% -$4.41M 0.23% 147
2021
Q4
$44.7M Buy
446,834
+121,663
+37% +$12.6M 0.35% 98
2021
Q3
$40.6M Sell
325,171
-31,580
-9% -$3.75M 0.32% 110
2021
Q2
$44.3M Sell
356,751
-45,590
-11% -$6.13M 0.32% 117
2021
Q1
$61.4M Buy
402,341
+110,954
+38% +$16.8M 0.46% 75
2020
Q4
$37.6M Sell
291,387
-77,713
-21% -$8.94M 0.28% 137
2020
Q3
$41.3M Buy
369,100
+150,179
+69% +$13.7M 0.36% 102
2020
Q2
$17.8M Buy
218,921
+122,924
+128% +$9.9M 0.16% 175
2020
Q1
$6.68M Buy
95,997
+11,185
+13% +$858K 0.08% 219
2019
Q4
$6.63M Buy
84,812
+77,722
+1,096% +$5.6M 0.05% 243
2019
Q3
$453K Sell
7,090
-7,508
-51% -$661K ﹤0.01% 286
2019
Q2
$1.26M Buy
+14,598
New +$1.11M 0.01% 282

Other funds holding GH